We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High Aldolase Levels Indicate Muscle or Liver Damage

By LabMedica International staff writers
Posted on 30 Oct 2009
A new aldolase assay is aimed at diagnosing patients who have muscle or liver damage.

Aldolase is an enzyme that helps convert glucose into energy and is found throughout the body but is primarily found in high levels in muscle tissue. Elevated levels in the bloodstream can indicate a patient that has muscle or liver damage.

When the muscles are diseased or damaged, such as in muscular dystrophy, the cells deteriorate and break open causing the contents of the cells, including aldolase, to spill into the bloodstream. Aldolase is also found in the liver and cardiac muscle of the heart. Damage or disease to these organs, such as chronic hepatitis or a heart attack, will also increase aldolase levels in the blood.

Measuring the amount of aldolase in the blood indicates the degree of muscle damage. The Randox (Crumlin, UK) aldolase test is for the quantitative determination in serum or plasma and can be run manually or on the Randox RX series or on other automatic and semi-automatic analyzers.

Randox develops, manufactures, and markets clinical diagnostic products worldwide. Core products include: biochip array technology; clinical chemistry analyzers and reagents; and quality controls; recombinant proteins and antibodies.

Related Links:

Randox



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated PCR System
OnePCR
New
Whole Blood Control
Lyphochek Whole Blood Control

Latest Clinical Chem. News

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules
30 Oct 2009  |   Clinical Chem.

First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns
30 Oct 2009  |   Clinical Chem.

Paper-Based Devices Outperform Existing Methods in Diagnosing Asymptomatic Malaria
30 Oct 2009  |   Clinical Chem.